Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% | -.--% | -.--% |
01:40pm | ROCHE HOLDINGS AG : UBS remains Neutral | ZD |
01:30pm | ROCHE HOLDINGS AG : Barclays sticks Neutral | ZD |
Sales 2024 * | 59.97B 65.65B 61.23B | Sales 2025 * | 63.83B 69.88B 65.17B | Capitalization | 179B 196B 183B |
---|---|---|---|---|---|
Net income 2024 * | 13.32B 14.58B 13.6B | Net income 2025 * | 14.75B 16.15B 15.06B | EV / Sales 2024 * | 3.22 x |
Net Debt 2024 * | 13.91B 15.23B 14.2B | Net Debt 2025 * | 7.76B 8.5B 7.93B | EV / Sales 2025 * | 2.93 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.9
x | Employees | 103,605 |
Yield 2024 * |
4.38% | Yield 2025 * |
4.53% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+22.86% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.74% | 219B | |
+6.54% | 199B | |
-8.75% | 149B | |
-5.21% | 146B |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock